Abstract
Overexpression of membrane-type-1 matrix metalloproteinase (MT1-MMP) in tumor cells has previously been shown to enhance tumor growth and metastasis. To establish if MT1-MMP is also able to confer tumorigenicity on nonmalignant epithelial cells, we transfected human MT1-MMP cDNA into Madin-Darby canine kidney (MDCK) cells expressing a tetracycline-repressible transactivator. Induction of MT1-MMP in the absence of doxycycline (Dox) was associated with activation of exogenous MMP-2 as well as with formation of large cysts and increased invasiveness in collagen matrices. Transfected cells were inoculated subcutaneously into two groups of nude mice, one of which received Dox to inhibit expression of MT1-MMP. Formation of tumor xenografts was observed in 11 of 17 mice maintained without Dox, but only in two of nine mice that received Dox (P<0.05). The xenografts were composed of tubular structures interspersed within a highly cellular stroma. The epithelial cells delimiting the lumen were polarized, as indicated by the basolateral distribution of Na,K-ATPase. Despite their differentiated appearance, the tumors lacked a well-defined boundary, and epithelial tubules invaded adjacent muscular layers. These results demonstrate that conditional expression of MT1-MMP in nonmalignant MDCK epithelial cells is by itself sufficient to drive formation of invasive tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI and Strongin AY . (2001). J. Biol. Chem., 276, 18415ā18422.
Deryugina EI, Bourdon MA, Jungwirth K, Smith JW and Strongin AY . (2000). Int. J. Cancer, 86, 15ā23.
Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA and Strongin A . (1997). J. Cell Sci., 110, 2473ā2482.
Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV and Strongin AY . (2002a). J. Biol. Chem., 277, 9749ā9756.
Deryugina EI, Soroceanu L and Strongin A . (2002b). Cancer Res., 62, 580ā588.
Dunbar LA and Caplan MJ . (2001). J. Biol. Chem., 276, 29617ā29620.
Egeblad M and Werb Z . (2002). Nat. Rev. Cancer, 2, 161ā174.
Feraille E and Doucet A . (2001). Physiol. Rev., 81, 345ā418.
Friedl P and Wolf K . (2003). Nat. Rev. Cancer, 3, 362ā374.
Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B and Beliveau R . (2001). FEBS Lett., 507, 231ā236.
Gossen M and Bujard H . (1992). Proc. Natl. Acad. Sci. USA, 89, 5547ā5551.
Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M and Yu DY . (2001). Cancer Res., 61, 984ā990.
Habelhah H, Okada F, Kobayashi M, Nakai K, Choi S, Hamada J, Moriuchi T, Kaya M, Yoshida K, Fujinaga K and Hosokawa M . (1999). Oncogene, 18, 1771ā1776.
Hotary K, Allen E, Brooks P, Datta N, Long M and Weiss SJ . (2003). Cell, 114, 33ā45.
Hotary K, Allen E, Punturieri A, Yana I and Weiss SJ . (2000). J. Cell Biol., 149, 1309ā1323.
Kadono Y, Okada Y, Namiki M, Seiki M and Sato H . (1998a). Cancer Res., 58, 2240ā2244.
Kadono Y, Shibahara K, Namiki M, Watanabe Y, Seiki M and Sato H . (1998b). Biochem. Biophys. Res. Commun., 251, 681ā687.
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H and Seiki M . (2001). J. Cell Biol., 153, 893ā904.
Koshikawa N, Giannelli G, Cirulli V, Miyazaki K and Quaranta V . (2000). J. Cell Biol., 148, 615ā624.
Liotta LA and Kohn EC . (2001). Nature, 411, 375ā379.
Lynch CC and Matrisian LM . (2002). Differentiation, 70, 561ā573.
Maffini MV, Soto AM, Calabro JM, Ucci AA and Sonnenschein C . (2004). J. Cell Sci., 117, 1495ā1502.
Mareel M and Leroy A . (2003). Physiol. Rev., 83, 337ā376.
Montesano R, Matsumoto K, Nakamura T and Orci L . (1991a). Cell, 67, 901ā908.
Montesano R, Pepper MS and Orci L . (1993). J. Cell Sci., 105, 1013ā1024.
Montesano R, Schaller G and Orci L . (1991b). Cell, 66, 697ā711.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M and Okada Y . (1997). J. Biol. Chem., 272, 2446ā2451.
Pepper MS, Belin D, Montesano R, Orci L and Vassalli JD . (1990). J. Cell Biol., 111, 743ā755.
Rabito CA, Tchao R, Valentich J and Leighton J . (1978). J. Membr. Biol., 43, 351ā365.
Reno F, Lombardi F and Cannas M . (2004). Biomaterials, 25, 3439ā3443.
Rodriguez-Boulan E and Nelson WJ . (1989). Science, 245, 718ā725.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M . (1994). Nature, 370, 61ā65.
Schenk S and Quaranta V . (2003). Trends Cell Biol., 13, 366ā375.
Seiki M . (2003). Cancer Lett., 194, 1ā11.
Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM and Noel A . (2002). FASEB J., 16, 555ā564.
Stamenkovic I . (2003). J. Pathol., 200, 448ā464.
Sternlicht MD, Bissell MJ and Werb Z . (2000). Oncogene, 19, 1102ā1113.
Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougie JP, Gray JW, Pinkel D, Bissell MJ and Werb Z . (1999). Cell, 98, 137ā146.
Sternlicht MD and Werb Z . (2001). Annu. Rev. Cell Dev. Biol., 17, 463ā516.
Stetler-Stevenson WG and Yu AE . (2001). Semin. Cancer Biol., 11, 143ā152.
Stiles CD, Desmond W, Chuman LM, Sato G and Saier MH . (1976). Cancer Res., 36, 1353ā1360.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA and Goldberg GI . (1995). J. Biol. Chem., 270, 5331ā5338.
Takino T, Miyamori H, Watanabe Y, Yoshioka K, Seiki M and Sato H . (2004). Cancer Res., 64, 1044ā1049.
Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z and Bissell MJ . (1998). Am. J. Pathol., 153, 457ā467.
Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H and Seiki M . (1996). Cancer Res., 56, 5678ā5683.
U HS, Boerner P, Rindler MJ, Chuman L and Saier Jr MH . (1985). J. Cell. Physiol., 122, 299ā307.
Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB and Bowden GT . (2003). Cancer Res., 63, 2292ā2299.
Vihinen P and Kahari VM . (2002). Int. J. Cancer, 99, 157ā166.
Weiss SJ and Pei D . (1996). J. Biol. Chem., 271, 9135ā9140.
Yana I and Seiki M . (2002). Clin. Exp. Metastasis, 19, 209ā215.
Zucker S, Pei D, Cao J and Lopez-Otin C . (2003). Curr. Top. Dev. Biol., 54, 1ā74.
Acknowledgements
We gratefully acknowledge the initial contribution of Dr J Soriano in setting up the MDCK Tet-Off expression system. We also thank Mrs P Couleru, J Rial-Robert and D Ben-Nasr for excellent technical assistance, Drs G Hosseini and A Wohlwend for helpful advice, N Dupont for secretarial work, Dr M Seiki for providing the human MT1-MMP probe and Dr L Orci for critical reading of the manuscript. This study was supported by Grants No. 31-61446.00 and 3100A0-101734 from the Swiss National Science Foundation (to RM) and NIH Grants CA83017 and CA77470 (to AYS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
SouliĆ©, P., Carrozzino, F., Pepper, M. et al. Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells. Oncogene 24, 1689ā1697 (2005). https://doi.org/10.1038/sj.onc.1208360
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208360